F 11782, a dual inhibitor of topoisomerases I and II with an original mechanism of action in vitro, and markedly superior in vivo antitumour activity, relative to three other dual topoisomerase inhibitors, intoplicin, aclarubicin and TAS-103. (Q40749728)
Jump to navigation
Jump to search
scientific article published on January 2000
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | F 11782, a dual inhibitor of topoisomerases I and II with an original mechanism of action in vitro, and markedly superior in vivo antitumour activity, relative to three other dual topoisomerase inhibitors, intoplicin, aclarubicin and TAS-103. |
scientific article published on January 2000 |
Statements
1 reference
F 11782, a dual inhibitor of topoisomerases I and II with an original mechanism of action in vitro, and markedly superior in vivo antitumour activity, relative to three other dual topoisomerase inhibitors, intoplicin, aclarubicin and TAS-103. (English)
1 reference
Etiévant C
1 reference
Kruczynski A
1 reference
Barret JM
1 reference
Perrin D
1 reference
van Hille B
1 reference
Guminski Y
1 reference
Hill BT
1 reference
1 January 2000
1 reference
1 reference
46
1 reference
2
1 reference
101-113
1 reference
Identifiers
1 reference
1 reference